CLIVATUZUMAB TETRAXETAN

UNII: 1D1F7UG35J
Preferred Substance Name: CLIVATUZUMAB TETRAXETAN

1462876-11-4
CLIVATUZUMAB TETRAXETAN [INN]
CLIVATUZUMAB TETRAXETAN [USAN]
HPAM4
HPAM-4
IGG-DOTA
IMMUNOGLOBULIN G1, ANTI-(MUCIN) (HUMAN-MUS MUSCULUS MONOCLONAL HPAM4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER, 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID CONJUGATE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

CLIVATUZUMAB TETRAXETAN

Synonyms and Mappings

Resources

Note